>Wyeth Investment Idea (GEOJIT)

# Wyeth Limited, a 51.12% subsidiary of Wyeth Inc.,USA has put up excellent performance
for Q3 FY2009. Net Sales grew@ 12.6% to Rs.93.8 crore (Rs.83.3 crore) led by 11.2%
growth in Pharma business to Rs.85.19 crore. Consumer Health Care business also grew @
14.3% to Rs.8.85 crore (Rs.7.74 crore). OPM% improved to 27.7% (25.8%) as a result of
operational efficiencies. Consequently, PBT was up by 20.3% to Rs.29.3 crore (Rs.24.4
crore) and PAT grew@ 18.5% to Rs.20.8 crore.

# For 9 months FY 2009, Net Sales grew @ 14 % to Rs.293.4 crore (Rs.257.3 crore) led by
14.4% growth in Pharma sales of Rs.264.81 crore. OPM% improved to 35.4% (34.7%)
PBIT% of Pharma business was up to 38.5% (35.2%), while Loss Before Interest and Tax of
Consumer Health Care business declined to 4.8%(9.8%). Consequently, PBT grew@ 15.5%
to Rs.114.6 crore (Rs.99.3 crore) and PAT was up by 17.1% to Rs.81.2 crore (Rs.69.3 crore).

To see full report : Wyeth